Similar Items: c‐Jun N‐terminal kinase 3 as a permissive regulator of β‐cell incretin responsiveness
- Adaptive islet biology and comprehensive incretin physiology: Emerging perspectives from Asia and Europe
- Real‐World vs. Randomized Trial Evidence for Incretin‐Based Therapies: A Narrative Review
- Recent advances in incretin biology and therapeutics: From glucose‐dependent insulinotropic polypeptide reappraisal to next‐generation agonists
- ChREBP drives β‐cell proliferation under metabolic stress but not in pregnancy‐induced β‐cell expansion
- Five‐year follow‐up of incretin‐based therapy in a patient with KCNJ11‐related permanent neonatal diabetes: Achieving insulin discontinuation and sulfonylurea reduction
- Impact of Imatinib Therapy on Immunometabolism to Promote β‐Cell Survival in Diabetes